Showing results (1711-1720 of 1,824) with videos related to
Sort By:
Pageof 183
Advances in Parasitology|December 8, 2007
Structure and content of the Entamoeba histolytica genomeC G Clark, U C M Alsmark, M Tazreiter, et al.Physical Review Letters|January 29, 2021
Record Energetics for an Inertial Fusion Implosion at NIFA B Zylstra, A L Kritcher, O A Hurricane, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 20, 2021
Update of the EPTN atlas for CT- and MR-based contouring in Neuro-OncologyDaniëlle B P Eekers, Dario Di Perri, Erik Roelofs, et al.Plos Pathogens|November 11, 2024
A model of lymphocryptovirus-associated post-transplant lymphoproliferative disorder in immunosuppressed Mauritian cynomolgus macaquesHelen L Wu, Whitney C Weber, Courtney M Waytashek, et al.Journal of Synchrotron Radiation|April 19, 2008
Key steps in the structure-based optimization of the hepatitis C virus NS3/4A protease inhibitor SCH503034Vincent Madison, Andrew J Prongay, Zhuyan Guo, et al.IEEE Transactions on Applied Superconductivity : a Publication of the IEEE Superconductivity Committee|July 31, 2019
Optimization of Time- and Code-Division-Multiplexed Readout for Athena X-IFUW B Doriese, S R Bandler, S Chaudhuri, et al.Journal of Medicinal Chemistry|April 21, 2007
Discovery of the HCV NS3/4A protease inhibitor (1R,5S)-N-[3-amino-1-(cyclobutylmethyl)-2,3-dioxopropyl]-3- [2(S)-[[[(1,1-dimethylethyl)amino]carbonyl]amino]-3,3-dimethyl-1-oxobutyl]- 6,6-dimethyl-3-azabicyclo[3.1.0]hexan-2(S)-carboxamide (Sch 503034) II. Key steps in structure-based optimizationAndrew J Prongay, Zhuyan Guo, Nanhua Yao, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 30, 2022
The European Particle Therapy Network (EPTN) consensus on the follow-up of adult patients with brain and skull base tumours treated with photon or proton irradiationLaurien De Roeck, Hiska L van der Weide, Daniëlle B P Eekers, et al.Basic Research in Cardiology|June 19, 2025
The innate immune receptor NLRX1 is a novel required modulator for mPTP opening: implications for cardioprotectionY Xiao, X Hu, C F Rudolphi, et al.Xenotransplantation|January 14, 2020
Viral opportunistic infections in Mauritian cynomolgus macaques undergoing allogeneic stem cell transplantation mirror human transplant infectious disease complicationsHelen L Wu, Whitney C Weber, Christine Shriver-Munsch, et al.Pageof 183